‘Hopeful milestone’: Health Canada approves 2nd drug to slow Alzheimer’s – National
Health Canada has approved a second drug that can slow the progression of Alzheimer’s disease. Donanemab, sold by American drugmaker Eli Lilly under the brand...
Tag : approves
Canada approves 2nd generic version of semaglutide – National
Descrease article font size Increase article font size The second generic version of semaglutide — the medication in brand-name drugs like Ozempic, Wegovy and Mounjaro...
Health Canada approves country’s 1st generic version of Ozempic – National
Health Canada has approved the first generic version of brand-name Ozempic. The department says Canada is the first G7 country to authorize generic semaglutide. The...
‘A landmark moment for the field’: FDA approves first-ever gene therapy for inherited deafness
The U.S. Food and Drug Administration (FDA) has approved the first-ever gene therapy for inherited deafness. The therapy, called Otarmeni, is approved to treat a...
Health Canada approves first needle-free treatment for allergic reactions – National
Health Canada has approved the use of Neffy, the first needle-free treatment meant to treat certain allergic reactions, like insect stings or bites, foods and...
U.S. FDA approves Eli Lilly’s GLP-1 oral weight-loss pill – National
The U.S. Food and Drug Administration (FDA) has approved a new GLP-1 weight-loss pill from drugmaker Eli Lilly, the agency said on Wednesday. The drug...